Paradoxical melanoma in situ arising in a depigmented patch secondary to immunotherapy

By afschroeder • July 1, 2026

Shah KS, Kang Y, Opene C. Paradoxical melanoma in situ arising in a depigmented patch secondary to immunotherapy. JAAD Case Rep. 2026 May 15;74:115-117. doi: 10.1016/j.jdcr.2026.05.020. PMID: 42381812; PMCID: PMC13316661.

Tags: Dermatology, immunotherapy, melanoma associated vitiligo, melanoma in situ, PD-1 inhibitor therapy, pembrolizumab, Publications, vitiligo, vitiligo-like depigmentation

Occupational epidemiology of acral lentiginous melanoma

Guo L, Kikuchi R, Armstrong AW, Chen SC. Occupational epidemiology of acral lentiginous melanoma. JID Innov. 2026 Apr 1;6(4):100473. doi: 10.1016/j.xjidi.2026.100473. PMID: 42383094; PMCID: PMC13316556.

A Response to: “Letter to the Editor Regarding ‘Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis'”

Augustin M, Armstrong AW, Issa NT, Petersen AS, von Eyben R, Festini T, Torres T. A Response to: "Letter to the Editor Regarding 'Anchored Matching-Adjusted[...]

Long-term disability outcomes in Hansen’s disease: A 20-year comparative study of Lepromatous vs. Tuberculoid Leprosy

Ma EJ, Adler BL, Armstrong AW, Ochoa MT. Long-term disability outcomes in Hansen's disease: A 20-year comparative study of Lepromatous vs. Tuberculoid Leprosy. PLoS Negl[...]